Sirnaomics Finds No Serious Adverse Events During Phase 1 Study for Coagulation Drug Sirnaomics (HKG:2257) said there were no dose-limiting toxicities or serious adverse events for the second group of...
Source LinkSirnaomics Finds No Serious Adverse Events During Phase 1 Study for Coagulation Drug Sirnaomics (HKG:2257) said there were no dose-limiting toxicities or serious adverse events for the second group of...
Source Link
Comments